Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin — DELTIC

Unresectable Intrahepatic Cholangiocarcinoma Clinical Trial

Official title:
Comparative, Prospective, Open-labeled, Randomized Phase II Study of Cisplatin or Carboplatin With Gemcitabine in Combination With Irinotecan-loaded Beads (LC or ONCOZENE) Versus Cisplatin or Carboplatin With Gemcitabine Alone in the Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma

Status Completed

Clinical Trial Summary

The purpose of this study is to find out if the combination of trans-arterial chemoembolization (LC or ONCOZENE BEAD) plus infusional chemotherapy is safe and more effective than just receiving the infusional chemotherapy alone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cholangiocarcinoma
Unresectable Intrahepatic Cholangiocarcinoma

Clinical Trial Details

NCT number	NCT01648023
Study type	Interventional
Source	University of Louisville
Contact
Status	Completed
Phase	Phase 2
Start date	July 2012
Completion date	September 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03942328` - Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer	Phase 1/Phase 2
Terminated	`NCT02256982` - A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma	N/A
Active, not recruiting	`NCT04175912` - Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver	Phase 2
Recruiting	`NCT06058663` - Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma	Phase 1
Recruiting	`NCT05738057` - Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma	Phase 2
Terminated	`NCT02994251` - A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma	Phase 2
Recruiting	`NCT05564403` - Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)	Phase 2
Active, not recruiting	`NCT03768414` - Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers	Phase 3
Completed	`NCT04301778` - Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma	Phase 2
Active, not recruiting	`NCT04251715` - mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma	Phase 2